Shaohua Chen Selected Research

Long Noncoding RNA

1/2023	m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis.
2/2022	An integrated analysis of the competing endogenous RNA network associated of prognosis of stage I lung adenocarcinoma.
1/2019	Long Non-coding RNA LINC00114 Facilitates Colorectal Cancer Development Through EZH2/DNMT1-Induced miR-133b Suppression.
11/2015	Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia.
9/2014	Inhibition of long non-coding RNA NEAT1 impairs myeloid differentiation in acute promyelocytic leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shaohua Chen Research Topics

Disease

48	Neoplasms (Cancer) 01/2024 - 04/2005
18	Leukemia 01/2022 - 09/2000
17	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 09/2000
12	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2022 - 04/2010
12	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 07/2022 - 11/2010
11	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2022 - 09/2000
8	Breast Neoplasms (Breast Cancer) 09/2023 - 01/2014
8	Nasopharyngeal Carcinoma 04/2023 - 05/2010
8	Acute Promyelocytic Leukemia 01/2021 - 04/2005
6	Inflammation (Inflammations) 01/2024 - 12/2011
6	Allergic Rhinitis 12/2016 - 01/2012
5	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 02/2014
5	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 09/2013
5	Myeloid Leukemia (Leukemia, Myelocytic) 10/2020 - 09/2000
4	Lymphoma (Lymphomas) 12/2023 - 04/2010
4	Carcinogenesis 01/2023 - 01/2015
4	Carcinoma (Carcinomatosis) 01/2023 - 02/2014
4	Communicable Diseases (Infectious Diseases) 01/2022 - 02/2014
4	Shock 04/2020 - 09/2013
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2013 - 02/2010
3	Microsatellite Instability 01/2024 - 01/2022
3	Adenocarcinoma of Lung 08/2022 - 01/2022
3	T-Cell Lymphoma (Lymphoma, T Cell) 07/2022 - 03/2015
3	Multiple Myeloma 03/2022 - 05/2011
3	Pathologic Complete Response 01/2022 - 04/2009
3	Infections 09/2021 - 12/2011
3	Secondary Hyperparathyroidism 11/2020 - 01/2018
3	Non-alcoholic Fatty Liver Disease 09/2015 - 09/2008
3	Obesity 01/2010 - 09/2008
2	Melanoma (Melanoma, Malignant) 01/2024 - 12/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 12/2016
2	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 07/2014
2	Hypoxia (Hypoxemia) 01/2023 - 01/2010
2	Stomach Neoplasms (Stomach Cancer) 06/2022 - 01/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 03/2014
2	Neoplasm Metastasis (Metastasis) 01/2020 - 05/2019
2	Colonic Neoplasms (Colon Cancer) 01/2020 - 01/2014
2	Diabetes Mellitus 11/2019 - 11/2019
2	Anemia 11/2019 - 11/2019
2	Hypertensive Nephropathy 11/2019 - 11/2019
2	Hypoalbuminemia 11/2019 - 11/2019
2	Arteriovenous Fistula 11/2019 - 11/2019
2	Renal Insufficiency (Renal Failure) 05/2018 - 01/2018
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2016 - 08/2009
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2014 - 06/2014
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2014 - 01/2014

Drug/Important Bio-Agent (IBA)

25	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 01/2002
17	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2016
17	Proteins (Proteins, Gene)FDA Link 06/2022 - 05/2006
12	AntigensIBA 09/2020 - 01/2002
8	Immunoglobulins (Immunoglobulin)IBA 01/2024 - 10/2018
8	RNA (Ribonucleic Acid)IBA 01/2023 - 02/2015
6	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 01/2010
6	Messenger RNA (mRNA)IBA 01/2021 - 04/2009
5	Long Noncoding RNAIBA 01/2023 - 09/2014
5	AllergensIBA 02/2022 - 09/2013
5	Small Interfering RNA (siRNA)IBA 12/2019 - 11/2010
4	CytokinesIBA 07/2022 - 12/2011
3	Immune Checkpoint InhibitorsIBA 12/2023 - 01/2020
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 03/2008
3	MicroRNAs (MicroRNA)IBA 01/2023 - 10/2018
3	Transcription Factors (Transcription Factor)IBA 12/2022 - 02/2015
3	Carrier Proteins (Binding Protein)IBA 01/2020 - 10/2013
3	Imatinib Mesylate (Gleevec)FDA Link 11/2019 - 04/2010
3	CalciumIBA 11/2019 - 01/2018
3	Tyrosine Kinase InhibitorsIBA 10/2017 - 09/2013
3	3' Untranslated Regions (3' UTR)IBA 12/2016 - 12/2012
3	SYBR Green IIBA 04/2012 - 11/2010
2	Lysine (L-Lysine)FDA Link 01/2024 - 07/2018
2	AcidsIBA 07/2023 - 08/2022
2	Folic Acid (Vitamin M)FDA LinkGeneric 04/2023 - 05/2019
2	Docetaxel (Taxotere)FDA Link 04/2023 - 05/2019
2	tissue-factor-pathway inhibitor 2 (PP5)IBA 04/2023 - 05/2019
2	ChromatinIBA 01/2023 - 02/2015
2	AntioxidantsIBA 01/2023 - 05/2015
2	Competitive Endogenous RNAIBA 02/2022 - 01/2022
2	Indicators and Reagents (Reagents)IBA 01/2022 - 02/2014
2	Immune Checkpoint ProteinsIBA 01/2022 - 04/2020
2	EnzymesIBA 01/2022 - 09/2020
2	Dendrimers (Dendrons)IBA 12/2021 - 07/2018
2	matrigelIBA 01/2021 - 10/2016
2	LigandsIBA 01/2020 - 09/2013
2	AminesIBA 12/2019 - 12/2019
2	Transferrin (beta 2 Transferrin)IBA 12/2019 - 07/2018
2	MethyltransferasesIBA 12/2019 - 09/2015
2	Peptides (Polypeptides)IBA 01/2019 - 10/2005
2	CollagenIBA 10/2016 - 05/2011
2	Inosine Triphosphate (ITP)IBA 10/2016 - 08/2009
2	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 09/2000
2	obatoclaxIBA 12/2014 - 06/2014
2	NF-kappa B (NF-kB)IBA 11/2014 - 01/2014

Therapy/Procedure

18	Immunotherapy 01/2024 - 01/2012
15	Therapeutics 04/2023 - 04/2010
7	Drug Therapy (Chemotherapy) 01/2024 - 10/2012
4	Radiotherapy 01/2020 - 05/2010
4	Hematopoietic Stem Cell Transplantation 11/2016 - 04/2011
3	Parathyroidectomy 11/2020 - 01/2018
2	Autologous Transplantation 05/2018 - 01/2018
2	Aftercare (After-Treatment) 03/2017 - 03/2008
2	Ligation 01/2014 - 07/2013